Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph not_applicable
3
75%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed250%
active_not_recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Interventions Against Fatigue in Patients With Myasthenia Gravis

NCT06659627
completedphase_1

Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

NCT04824443
completednot_applicable

Exercise and Vagus Nerve Stimulation in IBS

NCT06769516
unknownnot_applicable

Validation of Oxygen Uptake Efficiency Slope in Patients With Stroke

NCT03960918

Clinical Trials (4)

Showing 4 of 4 trials
NCT06659627Not Applicable

Interventions Against Fatigue in Patients With Myasthenia Gravis

Active Not Recruiting
NCT04824443Phase 1

Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

Completed
NCT06769516Not Applicable

Exercise and Vagus Nerve Stimulation in IBS

Completed
NCT03960918Not Applicable

Validation of Oxygen Uptake Efficiency Slope in Patients With Stroke

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4